Our Team
Board of Directors
LAUREN LEIMAN
Executive Director, BLOODPAC Consortium
President & Board Member
PHILLIP G. FEBBO, MD
Chief Scientific Officer & Chief Medical Officer, Veracyte
Treasurer & Board Member
PETER KUHN, PhD
Professor, University of Southern California
Board Member
LUCA QUAGLIATA, PhD
Vice President & Corporate Head, Medical Affairs Office, Products & Technology Sector, Thermo Fisher Scientific
Board Member
ROBERT LOBERG, PhD
Vice President, Life Cycle Leader - Oncology & Genetics, Roche
Secretary & Board Member
JAKE VINSON
Chief Executive Officer, Prostate Cancer Clinical Trials Consortium
Board Member
Scientific Advisory Committee
JIM GODSEY, PhD
BLOODPAC
ROBERT L. GROSSMAN, PhD
Professor, University of Chicago CTDS & Founder/Director, Open Commons Consortium
JERRY LEE, PhD
Professor and Director, Precision Health Network, Arizona State University
CAROLYN COMPTON, MD, PhD
Professor, Arizona State University
Scientific Co-Chair Committee
JONATHAN BADEN
Executive Director, Head of Precision Medicine, Bristol Myers Squibb
KELLI BRAMLETT
Executive Director, Molecular Oncology, Quest Diagnostics
Committee Chair
DARYA CHUDOVA, PhD
Chief Technology Officer, Guardant Health
JENNIFER DICKEY, PhD
Head of Regulatory and Quality, Labcorp
ELIZABETH MANSFIELD, PhD
Vice President, Regulatory Policy, Foundation Medicine
TRACI PAWLOWSKI, PhD
Vice President of R&D, NeoGenomics
ANGELA SILVESTRO
Director, Companion Diagnostics, GSK
JOHN SIMMONS
Global Vice President, Biopharma & Oncology Partnerships, Natera
BLOODPAC Team
BRIAN MINIE
Director of Data Science, BLOODPAC
CHEYENNE JANKIEWICZ
Program Manager, BLOODPAC
DORYS LOPEZ, PhD
Head of Scientific Communications, BLOODPAC
GINGER RIESSEN, CPA
Accountant, BLOODPAC

